Charles Moyer is Director at KING PHARMACEUTICALS INC (KG). They have made 3 open-market trades across 1 company since 2007, most recently 2015-05-20.
CIK 0001213334
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $29K since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CPTA | BUY | 2015-05-20 | 2015-05-20 | $17.17 | $9K | -0.3% | +2.6% | +2.6% |
| CPTA | BUY | 2014-05-16 | 2014-05-20 | $18.19 | $9K | -0.3% | +2.6% | +2.6% |
| CPTA | BUY | 2013-12-06 | 2013-12-10 | $19.46 | $12K | -0.3% | +2.6% | +2.6% |
| KG | SELL · 10b5-1 | 2010-06-01 | 2010-06-03 | $8.57 | $60K | -3.9% | +0.0% | +0.0% |
| KG | SELL · 10b5-1 | 2009-06-01 | 2009-06-02 | $9.48 | $57K | -3.9% | +0.0% | +0.0% |
| KG | SELL · 10b5-1 | 2007-09-04 | 2007-09-05 | $15.06 | $53K | -3.9% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.